Diadema Partners LP Oric Pharmaceuticals, Inc. Transaction History
Diadema Partners LP
- $233 Billion
- Q4 2024
A detailed history of Diadema Partners LP transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Diadema Partners LP holds 214,291 shares of ORIC stock, worth $1.6 Million. This represents 0.74% of its overall portfolio holdings.
Number of Shares
214,291Holding current value
$1.6 Million% of portfolio
0.74%Shares
1 transactions
Others Institutions Holding ORIC
# of Institutions
132Shares Held
67.3MCall Options Held
404KPut Options Held
6.4K-
Nextech Invest Ag5.29MShares$39.5 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$36.1 Million0.0% of portfolio
-
Viking Global Investors LP4.43MShares$33.1 Million0.12% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$32.8 Million5.85% of portfolio
-
Alkeon Capital Management LLC New York, NY3.9MShares$29.2 Million0.07% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $296M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...